Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial.

Pfeiffer-Jensen, M; Liao, D; Tarp, U; Deleuran, B; Stengaard-Pedersen, K; Venborg, J; Brock, B; Brock, C

Pfeiffer-Jensen, M; Liao, D; Tarp, U; Deleuran, B; Stengaard-Pedersen, K; Venborg, J; Brock, B; Brock, C.

Afiliação

Pfeiffer-Jensen M; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Liao D; Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Copenhagen, Denmark.
Tarp U; Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
Deleuran B; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Stengaard-Pedersen K; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Venborg J; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Brock B; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Brock C; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.

Scand J Rheumatol ; 52(5): 468-480, 2023 09.

Article em En | MEDLINE | ID: mdl-36315419

Assuntos

Antirreumáticos; Artrite Reumatoide; Adulto; Humanos; Inibidores do Fator de Necrose Tumoral/uso terapêutico; Monitoramento de Medicamentos; Estudos Prospectivos; Fator de Necrose Tumoral alfa; Adalimumab/uso terapêutico; Etanercepte/uso terapêutico; Infliximab/uso terapêutico; Artrite Reumatoide/tratamento farmacológico; Prescrições; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google